Goire GG, Salas FA, Oliva PS, Arias OY, Camejo SPIA, Knight FY, López MJC

Idioma: Español
Referencias bibliográficas: 24
Paginas:
Archivo PDF: 450.93 Kb.

RESUMEN

El síndrome de Takotsubo, o miocardiopatía por estrés, es una miocardiopatía reversible que se puede presentar como un síndrome coronario agudo, como un síndrome de insuficiencia cardíaca aguda o como una embolia sistémica. Aunque su mecanismo no se conoce con certeza; la hipótesis más aceptada está vinculada con una descarga de catecolaminas endógenas o exógenas. Si bien se reconocen desencadenantes o gatillos emocionales o físicos para su desarrollo, en ocasiones se presenta en ausencia de ellos. El síndrome de Takotsubo se caracteriza por una anomalía transitoria de la motilidad parietal del VI que comparte aspectos comunes con el síndrome coronario agudo (síntomas, anomalías del ECG, biomarcadores cardíacos elevados). Si bien se ha avanzado en el conocimiento de esta entidad, existen aún muchos aspectos sin aclarar. Presentamos un caso de una paciente que sufrió de dicha entidad clínica.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sato H. Tako-tsubo-like left ventricular dysfunctiondue to multivessel coronary spasm. In: K Kodama, K, Haze M Hori, eds. Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure. Tokyo: Kagakuhyoronsha Publishing Co; 1990. p56–64; (Article in Japanese).

2. Sharkey SW, Lesser JR, Maron MS, Maron BJ.Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature. J Am Coll Cardiol 2011;57: 1496–1497

3. Lyon AR, Bossone E, Schneider B, Sechtem U,Citro R, Underwood SR, Sheppard MN, Figtree GA, Parodi G, Akashi YJ, Ruschitzka F, Filippatos G, Mebazaa A, Omerovic E. Current state of knowledge on takotsubo syndrome: a position statement from the taskforce on takotsubo syndrome of the heart failure Association of the European Society of Cardiology. Eur J Heart Fail 2016; 18:8–27.

4. Deshmukh A, Kumar G, Pant S, Rihal C, MurugiahK, Mehta JL. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J 2012;164: 66–71 e1.

5. Templin C, Ghadri JR, Diekmann J, Napp LC,Bataiosu DR, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 2015; 373:929–938

6. Roshanzamir S, Showkathali R. Takotsubocardiomyopathy a short review. Curr Cardiol Rev 2013;9:191–196

7. Jung JM, Kim JG, Kim JB, Cho KH, Yu S, Oh K,Kim YH, Choi JY, Seo WK. Takotsubo-like myocardial dysfunction in ischemic stroke: a hospital-based registry and systematic literature review. Stroke 2016; 47:2729–2736

8. Finsterer J, Wahbi K. CNS disease triggeringTakotsubo stress cardiomyopathy. Int J Cardiol 2014;177:322–329.

9. Abraham J, Mudd JO, Kapur NK, Klein K,Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and betareceptor agonists. J Am Coll Cardiol 2009;53:1320–1325

10. Kume T, Kawamoto T, Okura H, Toyota E, NeishiY, Watanabe N, et al. Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J 2008; 72:106–108.

11. Bybee KA, Kara T, Prasad A, Lerman A, BarsnessGW, Wright RS, Rihal CS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004;141 : 858–865.

12. Prasad A, Lerman A, Rihal CS. Apical ballooningsyndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008;155:408–417.

13. Kawai S, Kitabatake A, Tomoike H. Guidelines fordiagnosis of takotsubo (ampulla) cardiomyopathy. Circ J 2007;71 :990–992.

14. Samuels MA. The brain-heart connection. Circulation 2007; 116:77–84

15. Haghi D, Papavassiliu T, Hamm K, Kaden JJ,Borggrefe M, Suselbeck T. Coronary artery disease in takotsubo cardiomyopathy. Circ J 2007;71 : 1092–1094.

16. Komesaroff PA, Esler MD, Sudhir K. Estrogensupplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 1999; 84:606–610.

17. Cherian J, Angelis D, Filiberti A, Saperia G. Cantakotsubo cardiomyopathy be familial? Int J Cardiol 2007;121 :74–75.

18. Sharkey SW, Windenburg DC, Lesser JR, MaronMS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010; 55:333–341

19. Ghadri JR, Cammann VL, Napp LC, Jurisic S,Diekmann J, Bataiosu DR, et al. International Takotsubo Registry. Differences in the clinical profile and outcomes of typical and atypical takotsubo syndrome: data from the International Takotsubo Registry. JAMA Cardiol 2016;1 :335–340.

20. Frangieh AH, Obeid S, Ghadri JR, Imori Y,D’Ascenzo F, Kovac M, Ruschitzka F, Luscher TF, Duru F, Templin C, Inter TAKC. ECG criteria to differentiate between Takotsubo (Stress) cardiomyopathy and myocardial infarction. J Am Heart Assoc 2016;5: e003418.

21. Murugiah K, Wang Y, Desai NR, Spatz ES, NutiSV, Dreyer RP, Krumholz HM. Trends in short- and long-term outcomes for Takotsubo cardiomyopathy among medicare fee-for-service beneficiaries, 2007 to 2012. JACC Heart Fail 2016; 4:197–205.

22. Sobue Y, Watanabe E, Ichikawa T, Koshikawa M,Yamamoto M, Harada M, Ozaki Y. Physically triggered Takotsubo cardiomyopathy has a higher inhospital mortality rate. Int J Cardiol 2017; 235:87–93.

23. Roffi M, Patrono C, Collet JP, Mueller C, ValgimigliM, Andreotti F, Bax JJ, Borger MA, et al. Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37:267–315.

24. Madias JE. If channel blocker ivabradine vs. beta-blockers for sinus tachycardia in patients with Takotsubo syndrome. Int J Cardiol 2016; 223:877–878.